𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Extended-release pramipexole in early Parkinson disease: A 33-week randomized controlled trial

✍ Scribed by Poewe, W.; Rascol, O.; Barone, P.; Hauser, R. A.; Mizuno, Y.; Haaksma, M.; Salin, L.; Juhel, N.; Schapira, A. H. V.

Book ID
111681790
Publisher
Lippincott Williams and Wilkins
Year
2011
Tongue
English
Weight
549 KB
Volume
77
Category
Article
ISSN
0028-3878

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Twice-daily, low-dose pramipexole in ear
Twice-daily, low-dose pramipexole in early Parkinson's disease: A randomized, placebo-controlled trial
✍ Karl Kieburtz; The Parkinson Study Group PramiBID Investigators πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 137 KB πŸ‘ 1 views

## Abstract To compare the safety and efficacy of low dosages of pramipexole given twice daily (bid) in early Parkinson's disease (PD) with those of a standard 3 times daily (tid) regimen in a randomized, double‐blind, placebo controlled trial involving 311 early PD patients not receiving dopaminer

Randomized, double-blind, multicenter ev
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
✍ Robert A. Hauser; Anthony H.V. Schapira; Olivier Rascol; Paolo Barone; Yoshikuni πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 220 KB πŸ‘ 1 views

## Abstract The objective of this study was to evaluate the efficacy and safety of pramipexole extended release (ER) administered once daily in early Parkinson's disease (PD). Pramipexole immediate release (IR) administered three times daily (TID) is an efficacious and generally well‐tolerated trea

Methylphenidate improves fatigue scores
Methylphenidate improves fatigue scores in Parkinson disease: A randomized controlled trial
✍ Dan A. MendonΓ§a; Krishe Menezes; Mandar S. Jog πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 117 KB

## Abstract Fatigue is a common nonmotor symptom in idiopathic Parkinson disease (IPD) that can prominently affect everyday function. This study was a randomized, double‐blind, placebo‐controlled trial evaluating methylphenidate for the treatment of fatigue in patients with IPD maintained on their